Etoposide and Iiird nerve paralysis - a phase IV clinical study of FDA data

Summary:

Iiird nerve paralysis is reported as a side effect among people who take Etoposide (etoposide), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Dexamethasone, and have Peripheral t-cell lymphoma unspecified.

The phase IV clinical study analyzes which people have Iiird nerve paralysis when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Iiird nerve paralysis?

Iiird nerve paralysis (totally closed eyelid and a down and out deviation of the eye) is found to be associated with 84 drugs and 513 conditions by eHealthMe. Check the latest studies of Iiird nerve paralysis.



On Jul, 05, 2026

77,756 people reported to have side effects when taking Etoposide.
Among them, 17 people (0.02%) have Iiird nerve paralysis.

Could Etoposide cause Iiird nerve paralysis?

Among these 17 people:

How long have people been on Etoposide when they have Iiird nerve paralysis? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Iiird nerve paralysis when taking Etoposide? *

  • female: 43.75 %
  • male: 56.25 %

What is the age of people who have Iiird nerve paralysis when taking Etoposide? *

  • 0-1: 0.0 %
  • 2-9: 6.67 %
  • 10-19: 13.33 %
  • 20-29: 0.0 %
  • 30-39: 60.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 20.0 %

What are other drugs people take besides Etoposide? *

  1. Methotrexate: 6 people, 35.29%
  2. Cyclophosphamide: 6 people, 35.29%
  3. Dexamethasone: 6 people, 35.29%
  4. Vincristine Sulfate: 4 people, 23.53%
  5. Prednisolone: 4 people, 23.53%
  6. Prednisone: 4 people, 23.53%
  7. Carboplatin: 3 people, 17.65%
  8. Lenalidomide: 3 people, 17.65%
  9. Dexamethasone Sodium Phosphate: 3 people, 17.65%
  10. Doxorubicin Hydrochloride: 2 people, 11.76%

What are other side effects people have besides Iiird nerve paralysis? *

  1. Abdominal Pain: 10 people, 58.82%
  2. Abscess Limb (limb infection): 10 people, 58.82%
  3. Retroperitoneal Haemorrhage (bleeding between the peritoneum and the posterior abdominal wall): 10 people, 58.82%
  4. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 10 people, 58.82%
  5. Pneumonia: 10 people, 58.82%
  6. Enterococcal Bacteraemia (presence of bacteria lactic acid in the blood): 10 people, 58.82%
  7. Vascular Pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity): 10 people, 58.82%
  8. Haematoma Infection (infection with collection of blood outside the blood vessels): 10 people, 58.82%
  9. Retroperitoneal Haematoma (blood clot between the peritoneum and the posterior abdominal wall): 3 people, 17.65%
  10. Pathogen Resistance: 3 people, 17.65%

What are the existing conditions these people have? *

  1. Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 10 people, 58.82%
  2. Retroperitoneal Haemorrhage (bleeding between the peritoneum and the posterior abdominal wall): 4 people, 23.53%
  3. Lymphoma (cancer that begins in immune system cells): 4 people, 23.53%
  4. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 23.53%
  5. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 3 people, 17.65%
  6. Retinoblastoma (tumour of retina): 2 people, 11.76%
  7. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 1 person, 5.88%
  8. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 5.88%
  9. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 5.88%
  10. Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Iiird nerve paralysis?

- Check whether Iiird nerve paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etoposide:

Iiird nerve paralysis treatments and more:

How severe was Iiird nerve paralysis and when was it recovered:

Expand to all the drugs that have ingredients of etoposide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Iiird nerve paralysis:

Browse all the conditions that are associated with Iiird nerve paralysis:


How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: